학술논문

Promoterless gene targeting approach combined with CRISPR/Cas9 efficiently corrects hemophilia B phenotype in neonatal mice
Document Type
Journal
Source
HUMAN GENE THERAPY; OCT 1 2021, 32 19-20, pA15-pA15, 1p.
Subject
Language
English
ISSN
15577422